Tongxieyaofang Decotion Alleviates IBS by Modulating CHRM3 and Gut Barrier

References

• Ford AC, Lacy BE, Talley NJ. Irritable bowel syndrome. New Engl J Med. 2017;376(26):2566–2578. doi:10.1056/NEJMra1607547
   PubMed Web of Science ®Google Scholar
• Fukudo S, Okumura T, Inamori M, et al. Evidence-based clinical practice guidelines for irritable bowel syndrome 2020. J Gastroenterol. 2021;56(3):193–217. doi:10.1007/s00535-020-01746-z
   PubMed Web of Science ®Google Scholar
• Bonetto S, Fagoonee S, Battaglia E, Grassini M, Saracco GM, Pellicano R. Recent advances in the treatment of irritable bowel syndrome. Pol Arch Intern Med. 2021;131(7–8):709–715. doi:10.20452/pamw.16067
   PubMedGoogle Scholar
• Holtmann GJ, Ford AC, Talley NJ. Pathophysiology of irritable bowel syndrome. Lancet Gastroenterol Hepatol. 2016;1(2):133–146. doi:10.1016/S2468-1253(16)30023-1
   PubMed Web of Science ®Google Scholar
• Chen M, Tang TC, Wang Y, et al. Randomised clinical trial: Tong-Xie-Yao-Fang granules versus placebo for patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2018;48(2):160–168. doi:10.1111/apt.14817
   PubMed Web of Science ®Google Scholar
• Liang S-B, Cao H-J, Kong L-Y, et al. Systematic review and meta-analysis of Chinese herbal formula tongxie yaofang for diarrhea-predominant irritable bowel syndrome: evidence for clinical practice and future trials. Front Pharmacol. 2022;13:904657.
   PubMed Web of Science ®Google Scholar
• Zhang M, Zheng Y, Li X, et al. Tong-Xie-Yao-Fang alleviates diarrhea-predominant irritable bowel syndrome in rats via the GCN2/PERK-eIF2α-ATF4 signaling pathway. Phytomedicine. 2022;107:154350.
   PubMed Web of Science ®Google Scholar
• Yin Y, Zhong L, Wang JW, Zhao XY, Zhao WJ, Kuang HX, Kuang H-X. Tong Xie Yao Fang relieves irritable bowel syndrome in rats via mechanisms involving regulation of 5-hydroxytryptamine and substance P. World J Gastroenterol. 2015;21(15):4536–4546. doi:10.3748/wjg.v21.i15.4536
   PubMed Web of Science ®Google Scholar
• Li J, Cui H, Cai Y, et al. Tong-Xie-Yao-Fang regulates 5-ht level in diarrhea predominant irritable bowel syndrome through gut microbiota modulation. Front Pharmacol. 2018;9:1110. doi:10.3389/fphar.2018.01110
   PubMed Web of Science ®Google Scholar
• Chen H, Kan Q, Zhao L, et al. Prophylactic effect of Tongxieyaofang polysaccharide on depressive behavior in adolescent male mice with chronic unpredictable stress through the microbiome-gut-brain axis. Biomed Pharmacother. 2023;161:114525.
   PubMed Web of Science ®Google Scholar
• Gallegos-Perez J-L, Limon A, Reyes-Ruiz JM, Alshanqeeti AS, Aljohi MA, Miledi R. Analysis of free ACh and 5-HT in milk from four different species and their bioactivity on 5-HT3and nACh receptors. Food Funct. 2014;5(7):1489–1494. doi:10.1039/C3FO60458F
   PubMed Web of Science ®Google Scholar
• Bennet SMP, Polster A, Törnblom H, et al. Global cytokine profiles and association with clinical characteristics in patients with irritable bowel syndrome. Am J Gastroenterol. 2016;111(8):1165–1176. doi:10.1038/ajg.2016.223
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhang H, Li N, et al. Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula. J Ethnopharmacol. 2023;309:116306. doi:10.1016/j.jep.2023.116306
   PubMed Web of Science ®Google Scholar
• Qin K, Dong C, Wu G, Lambert NA. Inactive-state preassembly of G(q)-coupled receptors and G(q) heterotrimers. Nat Chem Biol. 2011;7(10):740–747. doi:10.1038/nchembio.642
   PubMed Web of Science ®Google Scholar
• Wess J. Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. Annu Rev Pharmacol Toxicol. 2004;44(1):423–450. doi:10.1146/annurev.pharmtox.44.101802.121622
   PubMedGoogle Scholar
• McLean LP, Smith A, Cheung L, et al. Type 3 muscarinic receptors contribute to clearance of citrobacter rodentium. Inflamm Bowel Dis. 2015;21(8):1860–1871. doi:10.1097/MIB.0000000000000408
   PubMed Web of Science ®Google Scholar
• Cheru L, Saylor CF, Lo J. Gastrointestinal barrier breakdown and adipose tissue inflammation. Curr Obes Rep. 2019;8(2):165–174. doi:10.1007/s13679-019-00332-6
   PubMed Web of Science ®Google Scholar
• Al-Sadi R, Engers J, Haque M, King S, Al-Omari D, Ma TY. Matrix metalloproteinase-9 (MMP-9) induced disruption of intestinal epithelial tight junction barrier is mediated by NF-kappaB activation. PLoS One. 2021;16(4):e0249544. doi:10.1371/journal.pone.0249544
   PubMed Web of Science ®Google Scholar
• Zhang H-Y, Zeng H-R, Wei H-Z, et al. Tongxie-Yaofang formula regulated macrophage polarization to ameliorate DSS-induced colitis via NF-κB/NLRP3 signaling pathway. Phytomedicine. 2022;107:154455.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhang F, Mao L, et al. Bifico relieves irritable bowel syndrome by regulating gut microbiota dysbiosis and inflammatory cytokines. Eur J Nutr. 2022;62(1):139–155. doi:10.1007/s00394-022-02958-0
   PubMed Web of Science ®Google Scholar
• Guo L, Chen Q, Gao Y, et al. CDP-choline modulates cholinergic signaling and gut microbiota to alleviate DSS-induced inflammatory bowel disease. Biochem Pharmacol. 2023;217:115845. doi:10.1016/j.bcp.2023.115845
   PubMed Web of Science ®Google Scholar
• Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome. JAMA. 2015;313(9):949–958—.
   PubMed Web of Science ®Google Scholar
• Gong S, Zheng J, Zhang J, et al. Taxifolin ameliorates lipopolysaccharide-induced intestinal epithelial barrier dysfunction via attenuating NF-kappa B/MLCK pathway in a Caco-2 cell monolayer model. Food Res Int. 2022;158:111502.
   PubMed Web of Science ®Google Scholar
• He WQ, Wang J, Sheng JY, Zha JM, Graham WV, Turner JR. Contributions of myosin light chain kinase to regulation of epithelial paracellular permeability and mucosal homeostasis. Int J Mol Sci. 2020;21(3):993. doi:10.3390/ijms21030993
   PubMed Web of Science ®Google Scholar
• Brzozowski B, Mazur-Bialy A, Pajdo R, et al. Mechanisms by which stress affects the experimental and clinical inflammatory bowel disease (ibd): role of brain-gut axis. Curr Neuropharmacol. 2016;14(8):892–900. doi:10.2174/1570159X14666160404124127
   PubMed Web of Science ®Google Scholar
• Alizadeh M, Schledwitz A, Cheng K, Raufman JP. Mechanistic clues provided by concurrent changes in the expression of genes encoding the m(1) muscarinic receptor, beta-catenin signaling Proteins, and downstream targets in adenocarcinomas of the colon. Front Physiol. 2022;13:857563. doi:10.3389/fphys.2022.857563
   PubMed Web of Science ®Google Scholar
• Gros M, Gros B, Mesonero JE, Latorre E. Neurotransmitter dysfunction in irritable bowel syndrome: emerging approaches for management. J Clin Med. 2021;10(15):3429. doi:10.3390/jcm10153429
   PubMed Web of Science ®Google Scholar
• Sun P, Zhou K, Wang S, et al. Involvement of MAPK/NF-kappaB signaling in the activation of the cholinergic anti-inflammatory pathway in experimental colitis by chronic vagus nerve stimulation. PLoS One. 2013;8(8):e69424. doi:10.1371/journal.pone.0069424
   PubMed Web of Science ®Google Scholar
• Kim JE, Lee MR, Park JJ, et al. Quercetin promotes gastrointestinal motility and mucin secretion in loperamide-induced constipation of SD rats through regulation of the mAChRs downstream signal. Pharm Biol. 2018;56(1):309–317. doi:10.1080/13880209.2018.1474932
   PubMed Web of Science ®Google Scholar
• Chen D, Xiong Y, Lin Y, et al. Capsaicin alleviates abnormal intestinal motility through regulation of enteric motor neurons and MLCK activity: relevance to intestinal motility disorders. Mol Nutr Food Res. 2015;59(8):1482–1490. doi:10.1002/mnfr.201500039
   PubMed Web of Science ®Google Scholar
• Kan W, Adjobo-Hermans M, Burroughs M, et al. M3 muscarinic receptor interaction with phospholipase C beta3 determines its signaling efficiency. J Biol Chem. 2014;289(16):11206–11218. doi:10.1074/jbc.M113.538546
   PubMed Web of Science ®Google Scholar
• Layunta E, Forcen R, Grasa L. TLR2 and TLR4 modulate mouse ileal motility by the interaction with muscarinic and nicotinic receptors. Cells. 2022;11(11):1791. doi:10.3390/cells11111791
   PubMed Web of Science ®Google Scholar
• Chen Q, Zhang H, Sun CY, et al. Evaluation of two laboratory model methods for diarrheal irritable bowel syndrome. Mol Med. 2023;29(1):5. doi:10.1186/s10020-022-00599-x
   PubMed Web of Science ®Google Scholar
• Reyes EA, Castillo-Azofeifa D, Rispal J, et al. Epithelial TNF controls cell differentiation and CFTR activity to maintain intestinal mucin homeostasis. J Clin Invest. 2023;133(20). doi:10.1172/JCI163591
   Web of Science ®Google Scholar
• Garg P, Ravi A, Patel NR, et al. Matrix metalloproteinase-9 regulates MUC-2 expression through its effect on goblet cell differentiation. Gastroenterology. 2007;132(5):1877–1889. doi:10.1053/j.gastro.2007.02.048
   PubMed Web of Science ®Google Scholar
• Dolan B, Ermund A, Martinez-Abad B, Johansson MEV, Hansson GC. Clearance of small intestinal crypts involves goblet cell mucus secretion by intracellular granule rupture and enterocyte ion transport. Sci Signaling. 2022;15(752):eabl5848. doi:10.1126/scisignal.abl5848
   PubMed Web of Science ®Google Scholar
• Liu S, Huang Q, Huang Q, et al. The protective effects of electroacupuncture on intestinal barrier lesions in IBS and UC model. Sci Rep. 2023;13(1):7276. doi:10.1038/s41598-023-34182-z
   PubMed Web of Science ®Google Scholar
• Yu J, Liu T, Guo Q, Wang Z, Chen Y, Dong Y. Disruption of the intestinal mucosal barrier induced by high fructose and restraint stress is regulated by the intestinal microbiota and microbiota metabolites. Microbiol Spectr. 2023;11(2):e0469822. doi:10.1128/spectrum.04698-22
   PubMed Web of Science ®Google Scholar
• Augoff K, Hryniewicz-Jankowska A, Tabola R, Stach K. MMP9: a tough target for targeted therapy for cancer. Cancers. 2022;14(7):1847. doi:10.3390/cancers14071847
   PubMed Web of Science ®Google Scholar
• He F, Peng J, Deng XL, et al. Mechanisms of tumor necrosis factor-alpha-induced leaks in intestine epithelial barrier. Cytokine. 2012;59(2):264–272. doi:10.1016/j.cyto.2012.04.008
   PubMed Web of Science ®Google Scholar
• Xing Y, Xue S, Wu J, et al. Serum exosomes derived from irritable bowel syndrome patient increase cell permeability via regulating mir-148b-5p/rgs2 signaling in human colonic epithelium cells. Gastroenterol Res Pract. 2021;2021:6655900. doi:10.1155/2021/6655900
   PubMed Web of Science ®Google Scholar